Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-116.06%Return on Equity
VS
Market
Sector
Industry
History
$ 11.12Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information
Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENANTA PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ENTA - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 79.28M | $ -92.01M | -116.06% |
| 3/31/2025 | $ 93.54M | $ -96.42M | -103.08% |
| 12/31/2024 | $ 111.82M | $ -104.93M | -93.84% |
| 9/30/2024 | $ 128.81M | $ -116.05M | -90.09% |
| 6/30/2024 | $ 148.91M | $ -115.33M | -77.45% |
| 3/31/2024 | $ 166.11M | $ -131.74M | -79.3% |
| 12/31/2023 | $ 191.88M | $ -138.24M | -72.04% |
| 9/30/2023 | $ 216.74M | $ -133.82M | -61.74% |
| 6/30/2023 | $ 237.82M | $ -132.06M | -55.53% |
| 3/31/2023 | $ 269.38M | $ -124.69M | -46.29% |
Key Performance Insights, Last 5 Years
- ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at -7.94%.
- Over the past 5 years, ENANTA PHARMACEUTICALS INC's average ROE has been -52.2%.
- The median ROE for ENANTA PHARMACEUTICALS INC during this period was -43.19%
- ENANTA PHARMACEUTICALS INC reached its highest ROE over the past 5 years at -7.94%.
- The lowest ROE recorded by ENANTA PHARMACEUTICALS INC in the same timeframe -116.06%
ENANTA PHARMACEUTICALS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ENANTA PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -36.17M ] / Equity [ $ 455.58M ]
(=) ROE [ -7.94% ] ENTA - Return on Equity, Last 5 years
-116.06%
Minimum
Jun 30, 2025
-7.94%
Maximum
Sep 30, 2020
-52.2%
Average
-43.19%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.68%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.68% |